Text size Bristol-Myers Squibb is telling analysts this week that its portfolio of developing drugs could generate more sales than anyone expected. In a series of online meetings that started Monday, the drug maker raised its forecast for annual sales it could get from advanced-stage candidates from $ 15 billion …
Read More »Bristol-Myers Squibb Cancer Drug Pipeline Could Lead Sales of $ 20 Billion
